Depressive-like behavior is paired to monoaminergic alteration in a murine model of Alzheimer's disease

International Journal of Neuropsychopharmacology

Volumn 18, Issue 4, 2014, Pages 1-12

  Romano, Adele ^a   Pace, Lorenzo ^b   Tempesta, Bianca ^a   Lavecchia, Angelo Michele ^a   Macheda, Teresa ^b   Bedse, Gaurav ^a   Petrella, Antonio ^c   Cifani, Carlo ^d   Serviddio, Gaetano ^b   Vendemiale, Gianluigi ^b   Gaetani, Silvana ^a   Cassano, Tommaso ^b  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b UNIVERSITY OF FOGGIA   (Italy)

^c Puglia and Basilicata Experimental Zooprophylactic Institute   (Italy)

^d UNIVERSITY OF CAMERINO   (Italy)

Author keywords

Anxiety; Depression; Frontal cortex; Hippocampus; Monoaminergic neurotransmission; Triple transgenic model of AD

Indexed keywords

AMYLOID BETA PROTEIN; DESIPRAMINE; DOPAMINE; OXYGENASE; SEROTONIN; TAU PROTEIN; TRYPTOPHAN HYDROXYLASE; TYROSINE; BIOGENIC AMINE; CENTRAL NERVOUS SYSTEM AGENTS; MAPT PROTEIN, MOUSE; POTASSIUM; TYROSINE 3 MONOOXYGENASE;

ALZHEIMER DISEASE; AMYLOID PLAQUE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANXIETY; ARTICLE; BRAIN NERVE CELL; CAUDATE NUCLEUS; CONTROLLED STUDY; COPING BEHAVIOR; DEPRESSION; DOPAMINERGIC TRANSMISSION; EMOTION; FLUID INTAKE; FRONTAL CORTEX; GENOTYPE; GROOMING; HIPPOCAMPUS; IMMOBILITY; IMMUNOHISTOCHEMISTRY; LOCUS CERULEUS; MALE; MONOAMINERGIC SYSTEM; MOTOR PERFORMANCE; MOUSE; NEUROTRANSMISSION; NONHUMAN; NUCLEUS ACCUMBENS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PUTAMEN; SEROTONIN RELEASE; STIMULATION; VENTRAL HIPPOCAMPUS; 129 MOUSE; ANIMAL; BRAIN; C57BL MOUSE; DISEASE MODEL; DRUG EFFECTS; EXTRACELLULAR SPACE; METABOLISM; MOTOR ACTIVITY; PATHOLOGY; PHYSIOLOGY; PSYCHOLOGY; TRANSGENIC MOUSE;

ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; ANIMALS; ANXIETY; BIOGENIC MONOAMINES; BRAIN; CENTRAL NERVOUS SYSTEM AGENTS; DEPRESSION; DISEASE MODELS, ANIMAL; EXTRACELLULAR SPACE; MALE; MICE, 129 STRAIN; MICE, INBRED C57BL; MICE, TRANSGENIC; MOTOR ACTIVITY; POTASSIUM; TAU PROTEINS; TRYPTOPHAN HYDROXYLASE; TYROSINE 3-MONOOXYGENASE;

EID: 84926687645     PISSN: 14611457     EISSN: 14695111     Source Type: Journal    
DOI: 10.1093/ijnp/pyu020     Document Type: Article

References (43)

1. American Psychiatric Association (2007). Practice guideline for the treatment of patients with Alzheimer's disease and other dementias, second ed. Ann Intern Med 148:370-378.
2. Assal F, Cummings JL (2002) Neuropsychiatric symptoms in the dementias. Curr Opin Neurol 15:445-450.
3. Arsenault D, Julien C, Tremblay C, Calon F (2011) DHA improves cognition and prevents dysfunction of entorhinal cortex neurons in 3xTg-AD mice. PLOS ONE 6:e17397.
4. Ballard C, Lana MM, Theodoulou M, Douglas S, McShane R, Jacoby R, Kossakowski K, Yu LM, Juszczak E (2008) Investigators DART AD. A randomised, blinded, placebo-controlled trial in dementia patients continuing or stopping neuroleptics (the DART-AD trial). PLOS Med 5:e76.
5. Bambico FR, Cassano T, Dominguez-Lopez S, Katz N, Walker CD, Piomelli D, Gobbi G (2010) Genetic deletion of fatty acid amide hydrolase alters emotional behavior and serotonergic transmission in the dorsal raphe, prefrontal cortex, and hippocampus. Neuropsychopharmacology 35:2083-2100.
6. Bedse G, Romano A, Cianci S, Lavecchia AM, Elphick MR, LaFerla FM, Vendemiale G, Grillo C, Altieri F, Cassano T, Gaetani S (2014) Altered expression of the CB1 cannabinoid receptor in the triple transgenic mouse model of Alzheimer's disease. J Alzheimers Dis 40:701-712.
7. Belmaker RH, Agam G (2008) Major depressive disorder. N Engl J Med 358:55-68.
8. Billings LM, Oddo S, Green KN, McGaugh JL, LaFerla FM (2005) Intraneuronal Abeta causes the onset of early Alzheimer's disease-related cognitive deficits in transgenic mice. Neuron 45:675-688.
9. Carroll JC, Rosario ER, Chang L, Stanczyk FZ, Oddo S, LaFerla FM, Pike CJ (2007) Progesterone and estrogen regulate Alzheimerlike neuropathology in female 3xTg-AD mice. J Neurosci 27:13357-13365.
10. Cassano T, Romano A, Macheda T, Colangeli R, Cimmino CS, Petrella A, LaFerla FM, Cuomo V, Gaetani S (2011) Olfactory memory is impaired in a triple transgenic model of Alzheimer disease. Behav Brain Res 224:408-412.
11. Cassano T, Serviddio G, Gaetani S, Romano A, Dipasquale P, Cianci S, Bellanti F, Laconca L, Romano AD, Padalino I, LaFerla FM, Nicoletti F, Cuomo V, Vendemiale G (2012) Glutamatergic alterations and mitochondrial impairment in a murine model of Alzheimer disease. Neurobiol Aging 33:11211-112112.
12. Chen CP, Eastwood SL, Hope T, McDonald B, Francis PT, Esiri MM (2000) Immunocytochemical study of the dorsal and median raphe nuclei in patients with Alzheimer's disease prospectively assessed for behavioural changes. Neuropath Appl Neuro 26:347-355.
13. Espana J, Gimenez-Llort L, Valero J, Minano A, Rabano A, Rodriguez- Alvarez J, LaFerla FM, Saura CA (2010) Intraneuronal beta-amyloid accumulation in the amygdale enhances fear and anxiety in Alzheimer's disease transgenic mice. Biol Psychiatry 67:513-521.
14. Filali M, Lalonde R, Theriault P, Julien C, Calon F, Planel E (2012) Cognitive and non-cognitive behaviors in the triple transgenic mouse model of Alzheimer's disease expressing mutated APP, PS1, and Mapt (3xTg-AD). Behav Brain Res 234:334-342.
15. Franklin KBJ, Paxinos G (1997) The mouse brain in stereotaxic coordinates. San Diego, CA: Academic Press.
16. Gimenez-Llort L, Blazquez G, Canete T, Johansson B, Oddo S, Tobena A, LaFerla FM, Fernandez-Teruel A (2007) Modeling behavioral and neuronal symptoms of Alzheimer's disease in mice: a role for intraneuronal amyloid. Neurosci Biobehav Rev 31:125-147.
17. Gottfries CG (1990) Neurochemical aspects on aging and diseases with cognitive impairment. J Neurosci Res 27:541-547.
18. Green KN, Billings LM, Roozendaal B, McGaugh JL, LaFerla FM (2006) Glucocorticoids increase amyloid-beta and tau pathology in a mouse model of Alzheimer's disease. J Neurosci 26:9047-9056.
19. Guzman-Ramos K, Moreno-Castilla P, Castro-Cruz M, McGaugh JL, Martinez-Coria H, LaFerla FM, Bermudez-Rattoni F (2012) Restoration of dopamine release deficits during object recognition memory acquisition attenuates cognitive impairment in a triple transgenic mice model of Alzheimer's disease. Learn Mem 19:453-460.
20. Harkany T, Dijkstra IM, Oosterink BJ, Horvath KM, Abraham I, Keijser J, Van der Zee EA, Luiten PG (2000) Increased amyloid precursor protein expression and serotonergic sprouting following excitotoxic lesion of the rat magnocellular nucleus basalis: neuroprotection by Ca2+ antagonist nimodipine. Neuroscience 101:101-114.
21. Hebda-Bauer EK, Simmons TA, Sugg A, Ural E, Stewart JA, Beals JL, Wei Q, Watson SJ, Akil H (2013) 3xTg-AD mice exhibit an activated central stress axis during early-stage pathology. J Alzheimers Dis 33:407-422.
22. Leong C (2014) Antidepressants for depression in patients with dementia: a review of the literature. Consult Pharm 29:254-263.
23. Modrego PJ, Ferrandez J (2004) Depression in patients with mild cognitive impairment increases the risk of developing dementia of Alzheimer type: a prospective cohort study. Arch Neurol 61:1290-1293.
24. Nagatsu T, Iizuka R (1989) Tyrosine hydroxylase, tryptophan hydroxylase, and the biopterin cofactor in the brains from patients with Alzheimer's disease. J Neural Transm Park Dis Dement Sect 1:21.
25. Nelson RL, Guo Z, Halagappa VM, Pearson M, Gray AJ, Matsuoka Y, Brown M, Martin B, Iyun T, Maudsley S, Clark RF, Mattson MP (2007) Prophylactic treatment with paroxetine ameliorates behavioral deficits and retards the development of amyloid and tau pathologies in 3xTgAD mice. Exp Neurol 205:166-176.
26. Noristani HN, Olabarria M, Verkhratsky A, Rodriguez JJ (2010) Serotonin fibre sprouting and increase in serotonin transporter immunoreactivity in the CA1 area of hippocampus in a triple transgenic mouse model of Alzheimer's disease. Eur J Neurosci 32:71-79.
27. Noristani HN, Meadows RS, Olabarria M, Verkhratsky A, Rodriguez JJ (2011) Increased hippocampal CA1 density of serotonergic terminals in a triple transgenic mouse model of Alzheimer's disease: an ultrastructural study. Cell Death Dis 2:e210.
28. Nyberg P, Adolfsson R, Hardy JA, Nordberg A, Wester P, Winblad B (1985) Catecholamine topochemistry in human basal ganglia. Comparison between normal and Alzheimer brains. Brain Res 333:139-142.
29. Oddo S, Caccamo A, Kitazawa M, Tseng BP, LaFerla FM (2003a) Amyloid deposition precedes tangle formation in a triple transgenic model of Alzheimer's disease. Neurobiol Aging 24:1063-1070.
30. Oddo S, Caccamo A, Shepherd JD, Murphy MP, Golde TE, Kayed R, Metherate R, Mattson MP, Akbari Y, LaFerla FM (2003b) Tripletransgenic model of Alzheimer's disease with plaques and tangles: intracellular Abeta and synaptic dysfunction. Neuron 39:409-421.
31. Ojha J, Karmegam RV, Masilamoni JG, Terry AV, Cashikar AG (2011) Behavioral defects in chaperone-deficient Alzheimer's disease model mice. PLOS ONE 6:e16550.
32. Palmer AM, DeKosky ST (1993) Monoamine neurons in aging and Alzheimer's disease. J Neural Transm Gen Sect 91:135-159.
33. Pietropaolo S, Feldon J, Yee BK (2008) Age-dependent phenotypic characteristics of a triple transgenic mouse model of Alzheimer disease. Behav Neurosci 122:733-747.
34. Pietropaolo S, Sun Y, Li R, Brana C, Feldon J, Yee BK (2009) Limited impact of social isolation on Alzheimer-like symptoms in a triple transgenic mouse model. Behav Neurosci 123:181-195.
35. Pomara N, Sidtis J (2007) Possible therapeutic implication of Abeta disturbances in depression. Int J Geriatr Psychiatry 22:931-932.
36. Sepehry AA, Lee PE, Hsiung GY, Beattie BL, Jacova C (2012) Effect of selective serotonin reuptake inhibitors in Alzheimer's disease with comorbid depression: a meta-analysis of depression and cognitive outcomes. Drug Aging 29:793-806.
37. Steffens DC, Plassman BL, Helms MJ, Welsh-Bohmer KA, Saunders AM, Breitner JC (1997) A twin study of late-onset depression and apolipoprotein E epsilon 4 as risk factors for Alzheimer's disease. Biol Psychiatry 41:851-6.
38. Sterniczuk R, Antle MC, Laferla FM, Dyck RH (2010) Characterization of the 3xTg-AD mouse model of Alzheimer's disease: part 2. Behavioral and cognitive changes. Brain Res 1348:149- 55.
39. Yao J, Irwin RW, Zhao L, Nilsen J, Hamilton RT, Brinton RD (2009) Mitochondrial bioenergetic deficit precedes Alzheimer's pathology in female mouse model of Alzheimer's disease. Proc Natl Acad Sci USA 106:14670-5.
40. Yu S, Holsboer F, Almeida OF (2008) Neuronal actions of glucocorticoids: focus on depression. J Steroid Biochem Mol Biol 108:300-309.
41. Wilson KC, Mottram PG, Vassilas CA (2008) Psychotherapeutic treatments for older depressed people. Cochrane Database Syst Rev 23:CD004853.
42. Wuwongse S, Chang RC, Law AC (2010) The putative neurodegenerative links between depression and Alzheimer's disease. Prog Neurobiol 91:362-375.
43. Zhou FC, Azmitia EC, Bledsoe S (1995) Rapid serotonergic fiber sprouting in response to ibotenic acid lesion in the striatum and hippocampus. Brain Res Dev Brain Res 84:89-98.